Self-Study HBV Lessons
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 6 Overview
Choosing an Initial HBV Treatment Regimen - 0%Topic 1
BackgroundActivities- 0%Topic 2
Oral Antiviral Therapy Options for HBVActivities- 0%Topic 3
Peginterferon-Based Therapy for HBVActivities- 0%Topic 4
Choosing Oral Antivirals versus PeginterferonChoosing an Initial HBV Treatment Regimen Overview
About this Lesson
Last Updated: February 18th, 2020CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: January 1st, 2020CNE and CME Review: December 1st, 2022CNE and CME Expiration: November 30th, 2025 (2nd Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE2nd Edition
This is a substantial revision of the original Lesson. The previous edition was titled Choosing an Initial HBV Treatment Regimen and available until December 1st, 2022.Learning Objectives
- Provide rationale for choosing an oral antiviral or interferon-based therapy to treat chronic HBV infection
- Name the three preferred oral antivirals for initial treatment of chronic HBV infection
- Discuss potential adverse effects with medications used to treat chronic HBV infection
- List situations when interferon-based therapy is contraindicated for treatment of chronic HBV
- Recognize special circumstances that warrant modification of standard treatment options for chronic HBV infection
Lesson Contributors
Authors
H. Nina Kim, MD, MScH. Nina Kim, MD, MSc
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
- 0%Topic 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE approved byOregon Nurses Association
- HBV Medications
- Self-Study Modules CNE/CME
- HBV Epidemiology
- HBV Screening, Testing, and Diagnosis
- HBV Immunizations
- Initial Evaluation of Persons with Chronic Hepatitis B
- When to Initiate HBV Treatment
- Choosing an Initial HBV Treatment Regimen
- Monitoring Persons On and Off HBV Therapy
- Preventing HBV Perinatal Transmission
- Screening for Hepatocellular Carcinoma
- Occupational HBV Postexposure Prophylaxis
- Hepatitis B Reactivation in the Setting of Immunosuppression
Quick Reference
- HBV Epidemiology
- HBV Screening, Testing, and Diagnosis
- HBV Immunizations
- Initial Evaluation of Persons with Chronic Hepatitis B
- When to Initiate HBV Treatment
- Choosing an Initial HBV Treatment Regimen
- Monitoring Persons On and Off HBV Therapy
- Preventing HBV Perinatal Transmission
- Screening for Hepatocellular Carcinoma
- Occupational HBV Postexposure Prophylaxis
- Hepatitis B Reactivation in the Setting of Immunosuppression
- Clinical ChallengesHepatitis B Primary Care Guidance Master Bibliography
Contributors - Tools & Calculators
Copyright © 2025 Hepatitis B Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhbvc-master-00a08ce5-2025-03-05-225844